Resistance to type 2 diabetes mellitus: a matter of hormesis?
- PMID: 22024974
- DOI: 10.1038/nrendo.2011.158
Resistance to type 2 diabetes mellitus: a matter of hormesis?
Abstract
Type 2 diabetes mellitus is characterized by subclinical systemic inflammation and impaired regulation of blood glucose levels. Interestingly, impairment of glycemic control occurs despite substantial insulin secretion early in the course of this disease. Dysfunction of several organs (including pancreatic islets, liver, skeletal muscle, adipose tissue, gut, hypothalamus and the immune system) has been implicated in the pathogenesis of type 2 diabetes mellitus. However, diabetes-promoting lifestyle factors do not inevitably cause disease in all persons exposed. Hence, defense mechanisms must exist that can keep the detrimental influence of these risk factors at bay. Hormesis describes the phenomenon that exposure to a mild stressor confers resistance to subsequent, otherwise harmful, conditions of increased stress. This Review discusses the emerging concept that the effectiveness of an adaptive (hormetic) response to detrimental lifestyle factors determines the extent of protection from progression to type 2 diabetes mellitus. Further analysis of these protective hormetic responses at the molecular level should help to identify novel targets for preventive or therapeutic intervention in patients at risk of developing type 2 diabetes mellitus or those with overt disease.
Similar articles
-
Resistance to diabetes-promoting lifestyle factors -- what is the mechanism?Diabetes Res Clin Pract. 2012 Aug;97(2):172-4. doi: 10.1016/j.diabres.2012.06.006. Epub 2012 Jul 5. Diabetes Res Clin Pract. 2012. PMID: 22771053
-
Sex hormonal regulation and hormesis in aging and longevity: role of vitagenes.J Cell Commun Signal. 2014 Dec;8(4):369-84. doi: 10.1007/s12079-014-0253-7. Epub 2014 Nov 9. J Cell Commun Signal. 2014. PMID: 25381162 Free PMC article.
-
Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells.Mol Aspects Med. 2016 Jun;49:49-77. doi: 10.1016/j.mam.2016.03.001. Epub 2016 Mar 21. Mol Aspects Med. 2016. PMID: 27012748 Review.
-
Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.Vitam Horm. 2014;95:195-222. doi: 10.1016/B978-0-12-800174-5.00008-9. Vitam Horm. 2014. PMID: 24559919 Review.
-
Genetic susceptibility, lifestyle intervention and glycemic changes among women with prior gestational diabetes.Clin Nutr. 2020 Jul;39(7):2144-2150. doi: 10.1016/j.clnu.2019.08.032. Epub 2019 Sep 10. Clin Nutr. 2020. PMID: 31542245 Free PMC article. Clinical Trial.
Cited by
-
Insulin translates unfavourable lifestyle into obesity.BMC Med. 2018 Dec 13;16(1):232. doi: 10.1186/s12916-018-1225-1. BMC Med. 2018. PMID: 30541568 Free PMC article. Review.
-
Emerging Roles for Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) in Pancreatic Beta Cells and Diabetes.Front Physiol. 2018 Oct 16;9:1457. doi: 10.3389/fphys.2018.01457. eCollection 2018. Front Physiol. 2018. PMID: 30386256 Free PMC article. Review.
-
qPCR Analysis Reveals Association of Differential Expression of SRR, NFKB1, and PDE4B Genes With Type 2 Diabetes Mellitus.Front Endocrinol (Lausanne). 2022 Jan 3;12:774696. doi: 10.3389/fendo.2021.774696. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35046895 Free PMC article.
-
Hormetic effect of rotenone in primary human fibroblasts.Immun Ageing. 2015 Sep 16;12:11. doi: 10.1186/s12979-015-0038-8. eCollection 2015. Immun Ageing. 2015. PMID: 26380578 Free PMC article.
-
Cellular Signaling Pathways in Insulin Resistance-Systems Biology Analyses of Microarray Dataset Reveals New Drug Target Gene Signatures of Type 2 Diabetes Mellitus.Front Physiol. 2017 Jan 25;8:13. doi: 10.3389/fphys.2017.00013. eCollection 2017. Front Physiol. 2017. PMID: 28179884 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical